Measles Eradication Via Vaccination: The Ultimate Nirvana Fallacy

August 7, 2023

Measles Eradication via Vaccination is the Ultimate Nirvana Fallacy: Vaccine Failure, Not So-Called ‘Anti-Vaxxers’, Explain Measles Outbreaks

We’ve been here before, and we’ll be here again, and again, and again. Look into your vaccine exemption rights in your state. We fought to keep your rights to choose. You might want to understand.

JAMES LYONS-WEILER
JUL 26, 2023

It seems every few years when the peak of the normal cycling of measles cases comes in, those who profit from vaccination and ad revenue from Pharma freak out and go on a rampage against people who decline the MMR vaccine for their children.

The Nirvana Fallacy of a world without measles due to 100% vaccination coverage has been disproven over and over with real-world data on outbreaks in highly vaccinated populations – and breakthrough infections in the vaccinated.

That’s vaccine failure, plain and simple. Let’s not forget about two former Merck employees, both virologists named Stephen A. Krahling and Joan A. Wlochowski.

From Jon Rapport:

“They’re insiders. They’ve leveled devastating charges against the company, which manufactures the MMR vaccine and sells it to the federal government.

In 2010, the whistleblowers filed a suit against Merck. The suit drags on in court (“UNITED STATES OF AMERICA et al. v. MERCK & CO.,” Case No. 2:10-cv-04374-CDJ).

The Huffington Post reports on the charges in the suit (See: Merck Has Some Explaining To Do Over Its MMR Vaccine Claims, 9/24/2014, updated: 11/27/2014):

“…former Merck scientists [claim] that Merck ‘fraudulently misled the government and omitted, concealed, and adulterated material information regarding the efficacy of its mumps vaccine in violation of the FCA [False Claims Act].’”

“According to the whistleblowers’ court documents, Merck’s misconduct was far-ranging: It ‘failed to disclose that its mumps vaccine was not as effective as Merck represented, (ii) used improper testing techniques, (iii) manipulated testing methodology, (iv) abandoned undesirable test results, (v) falsified test data, (vi) failed to adequately investigate and report the diminished efficacy of its mumps vaccine, (vii) falsely verified that each manufacturing lot of mumps vaccine would be as effective as identified in the labeling, (viii) falsely certified the accuracy of applications filed with the FDA, (ix) falsely certified compliance with the terms of the CDC purchase [of the MMR vaccine] contract, (x) engaged in the fraud and concealment described herein for the purpose of illegally monopolizing the U.S. market for mumps vaccine, (xi) mislabeled, misbranded, and falsely certified its mumps vaccine, and (xii) engaged in the other acts described herein to conceal the diminished efficacy of the vaccine the government was purchasing.’”

“These fraudulent activities, say the whistleblowers, were designed to produce test results that would meet the FDA’s requirement that the mumps vaccine was 95 percent effective. To the whistleblowers’ delight, the judge dismissed Merck’s objections to the case proceeding, finding the whistleblowers had plausible grounds on all of the claims lodged against Merck.” The whistleblowers’ charges include detailed specifics on how Merck cheated, in order to produce the false conclusion that the mumps component of the MMR vaccine was 95% effective. For example, Merck placed rabbit antibodies into blood samples—pretending these were human antibodies signaling a high level of immune response to the vaccine.”

[From Two More MMR Vaccine Whistleblowers: They’re Suing]

Below is a letter sent by Cindy Bevington Olmstead (LinkedIn) to Margaret Wente at the Globe and Mail, Canada in July of 2013. Wente had published an article attempting to lay the blame for a local measles outbreak on people who choose to not have their children vaccinated with the measles, mumps & rubella (MMR) vaccine.

The problem with blaming so-called “Anti-vaxxers” is that as far as assessing causality goes, Science says it’s not AVers who are responsible. They just help provide evidence that the vaccine efficacy is waning. More on that in a moment. Here’s Cindy’s letter:

“Dear Ms. Wente,

As a journalist, you should do your homework Ms. Wente.

If you had done so, you would know that measles often occurs in fully vaccinated populations (http://www.ncbi.nlm.nih.gov/pubmed/3821823), that the vaccine often does not work if the vaccinee has exposure to the sun or UVR rays around the time of vaccination (http://www.springerlink.com/content/v545057823230786/)*, that the active form of vitamin D (1,25(OH)2D3), derived from UVR-supported biosynthesis has well-documented immunomodulatory effects, and that there has been concern that increased exposure to UVR due to stratospheric ozone depletion could hamper the effectiveness of vaccines, particularly BCG, measles, and hepatitis (http://www.who.int/globalchange/publications/climatechangechap8.pdf).

You would also know that Harvard University researchers have found that because measles occur in highly vaccinated populations, VACCINATED PERSONS ARE A GREATER RISK TO THE UNVACCINATED than vice versa (See “AN EXPLOSIVE POINT-SOURCE MEASLES OUTBREAK IN A HIGHLY VACCINATED POPULATION: MODES OF TRANSMISSION AND RISK FACTORS FOR DISEASE https://academic.oup.com/aje/article-abstract/129/1/173/58793”) and that based on measles dynamics for industrialized countries, high birth rate regions should experience regular annual epidemics (See http://www.cidd.psu.edu/research/synopses/measles-outbreaks-niger/?searchterm=measles) because measles outbreaks come in waves just like pertussis.

If you bothered to go even a little further in your research, you would know that vaccine researchers have also found that EXPOSURE TO NATURAL MEASLES IS IMPORTANT in maintaining protective antibody levels among vaccinated children (http://aje.oxfordjournals.org/content/149/4/304.long) and that several studies have shown that measles or rubella-like illnesses in MMR vaccinated children are caused by other viruses.

Then again, most journalists these days don’t bother to do their homework so I can understand why you continue to perpetuate the vaccine sales propaganda, blaming non-vaccinated children on the measles outbreaks, along with the rest of the media, which has grown so lazy they don’t question anything that’s fed to them anymore. So sad that as intelligent as you are you haven’t bothered to look up the data for yourself.

[Globe & Mail article: Measles is back. It had help – The Globe and Mail (archive.org)]

Here are some additional fun facts about measles vaccine failure:

“Of the 194 measles virus sequences obtained in the United States in 2015, 73 were identified as vaccine sequences (R. J. McNall, unpublished data) – 37.6%”

Roy et al., 2017. Rapid Identification of Measles Virus Vaccine Genotype by Real-Time PCR J of Clinical Microbiol 55:735-743.

“Approximately 2% to 7% of children who receive only 1 dose of MMR vaccine fail to respond to it, i.e., they experience primary vaccine failure. MMR vaccine failure can occur because of passive antibodies in the vaccine recipient, immaturity of the immune system, damaged vaccine, or other reasons. “

CDC Pink Book. Measles.

In measles-endemic areas, breakthrough cases represent less than 10% of total infections, while in areas with high vaccination coverage, these are over 10% of the total. Two different vaccination failures have been described: primary vaccination failure, which consists in the complete absence of humoral response and occurs in around 5% of vaccinated individuals; and secondary vaccination failure is due to waning immunity or incomplete immunity and occurs in 2–10% of vaccinees.

Fappani C, Gori M, Canuti M, Terraneo M, Colzani D, Tanzi E, Amendola A, Bianchi S. Breakthrough Infections: A Challenge towards Measles Elimination? Microorganisms. 2022 Aug 4;10(8):1567. doi: 10.3390/microorganisms10081567. PMID: 36013985; PMCID: PMC9413104.

“Two Vitamin A megadoses (200,000 international units (IUs) on each day for two days) lowered the number of deaths from measles in hospitalized children under the age of two years. Two doses of vitamin A are not considered to be too expensive and are not likely to produce adverse effects.”

Huiming Y, Chaomin W, Meng M. Vitamin A for treating measles in children. Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD001479. doi: 10.1002/14651858.CD001479.pub3. PMID: 16235283; PMCID: PMC7076287.

We’re going to see measles cases in increasing numbers as vaccine efficacy continues to wane. There’s nothing anyone can do about it. The community of individuals who bother to understand the dynamics involved will not tolerate the restriction of personal and civil liberties over the Nirvana Fallacy of measles eradication.

Twentyfive mainstream studies that demonstrate these products fail, have limited duration, prevent mothers from delivering antibodies to infants, and will in the long-term cause as many problems as they solve – compromising human resistance to measles without remotely eliminating it:

Bolotin et al. What is the evidence to support a correlate of protection for measles? A systematic review. J Infect Dis 2020;221:1576–83

Cherry, J. D., & Zahn, M. (2018). Clinical Characteristics of Measles in Previously Vaccinated and Unvaccinated Patients in California. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 67(9), 1315–1319. https://doi.org/10.1093/cid/ciy286

Fiebelkorn, A. P., Coleman, L. A., Belongia, E. A., Freeman, S. K., York, D., Bi, D., … Beeler, J. (2016). Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults. The Journal of Infectious Diseases, 213(7), 1115–1123. https://doi.org/10.1093/infdis/jiv555

Glass, K., & Grenfell, B. T. (2004). Waning immunity and subclinical measles infections in England. Vaccine, 22(29-30), 4110–4116. ​https://pubmed.ncbi.nlm.nih.gov/15364464/

Gibney, K. B., Attwood, L. O., Nicholson, S., Tran, T., Druce, J., Healy, J., … Cross, G. B. (2019). Emergence of attenuated measles illness among IgG positive/IgM negative measles cases, Victoria​, Australia 2008-2017. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciz363

Heffernan J.M., & Keeling M.J. (2009). Implications of vaccination and waning immunity. Proceedings of the Royal Society B: Biological Sciences, 276(1664), 2071–2080. https://doi.org/10.1098/rspb.2009.0057

Kang, H. J., Han, Y. W., Kim, S. J., Kim, Y.-J., Kim, A.-R., Kim, J. A., … Kim, S. S. (2017). An increasing, potentially measles-susceptible population over time after vaccination in Korea. Vaccine, 35(33), 4126–4132. https://doi.org/10.1016/j.vaccine.2017.06.058

Kang, J. H., & Yoo, J.-H. (2019). The Measles Strikes Back. Journal of Korean Medical Science, 34(6), e59. https://doi.org/10.3346/jkms.2019.34.e59

Kontio, M., Jokinen, S., Paunio, M., Peltola, H., & Davidkin, I. (2012). Waning antibody levels and avidity: implications for MMR vaccine-induced protection. The Journal of Infectious Diseases, 206(10), 1542–1548. https://doi.org/10.1093/infdis/jis568

Leuridan, E., Hens, N., Hutse, V., Ieven, M., Aerts, M., & Van Damme, P. (2010). Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ , 340, c1626. https://doi.org/10.1136/bmj.c1626

Liu, Y., Liu, Z., Deng, X., Hu, Y., Wang, Z., Lu, P., … Zhu, F.-C. (2018). Waning immunity of one-dose measles-mumps-rubella vaccine to mumps in children from kindergarten to early school age: a prospective study. Expert Review of Vaccines, 17(5), 445–452.​ ​https://doi.org/10.1080/14760584.2018.1445529

Markowitz LE, Albrecht P, Rhodes P, Demonteverde R, Swint E, Maes EF, Powell C, Patriarca PA., ‘Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.’, Pediatrics. 1996 Jan;97(1):53-8.

Melenotte C, Zandotti C, Gautret P, Parola P, Raoult D. Measles: is a new vaccine approach needed? Lancet Infect Dis 2018; 18:1060–1.

Mossong, J., & Muller, C. P. (2003). Modelling measles re-emergence as a result of waning of immunity in vaccinated populations. Vaccine, 21(31), 4597–4603.

Mossong, J., Nokes, D. J., Edmunds, W. J., Cox, M. J., Ratnam, S., & Muller, C. P. (1999). Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. American Journal of Epidemiology, 150(11), 1238–1249.

Nkowane, B. M., Bart, S. W., Orenstein, W. A., & Baltier, M. (1987). Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures. American Journal of Public Health, 77(4), 434–438. https://doi.org/10.2105/ajph.77.4.434

Orenstein, W. A., Strebel, P. M., Papania, M., Sutter, R. W., Bellini, W. J., & Cochi, S. L. (2000). Measles eradication: is it in our future? American Journal of Public Health, 90(10), 1521–1525. Retrieved from​ ​https://www.ncbi.nlm.nih.gov/pubmed/11029981

Pannuti, C. S., Morello, R. J., Moraes, J. C. de, Curti, S. P., Afonso, A. M. S., Camargo, M. C. C., & Souza, V. A. U. F. de. (2004a). Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic. Clinical and Diagnostic Laboratory Immunology, 11(1), 119–122.

Paunio et al, ‘Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age’, Epidemiol Infect. 2000 Apr;124(2):263-71.

Stanley A Plotkin, ‘Is There a Correlate of Protection for Measles Vaccine?’, The Journal of Infectious Disease 1 November 2019

Poland, GA and RM. Jacobson, ‘The Re-Emergence of Measles in Developed Countries: Time to Develop the Next-Generation Measles Vaccines?’, Vaccine. 2012 Jan 5; 30(2): 103–104., https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905323/

Rosen JB, Rota JS, Hickman CJ, Sowers SB, Mercader S, Rota PA, Bellini WJ, Huang AJ, Doll MK, Zucker JR, Zimmerman CM., ‘Outbreak of measles among persons with prior evidence of immunity, New York City, 2011’, Clin Infect Dis. 2014 May;58(9):1205-10. doi: 10.1093/cid/ciu105. Epub 2014 Feb 27

Felicia Roy, Lillian Mendoza, Joanne Hiebert, Rebecca J. McNall, Bettina Bankamp, Sarah Connolly, Amy Lüdde, Nicole Friedrich, Annette Mankertz, Paul A. Rota, Alberto Severini , ‘Rapid Identification of Measles Virus Vaccine Genotype by Real-Time PCR’ https://jcm.asm.org/content/55/3/735″Of the 194 measles virus sequences obtained in the United States in 2015, 73 were identified as vaccine sequences (RJ McNall, unpublished data)”.

Waaijenborg S., Hahné S.J.M., Mollema L., Smits G.P., Berbers G.A.M., van der Klis F.R.M., de Melker H.E., and Wallinga J., ‘Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage’, J Infect Dis. 2013 Jul 1; 208(1): 10–16

Zhao et al, ‘Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination’ Virol J. 2010; 7: 87., Published online 2010 May 6. doi: 10.1186/1743-422X-7-87.

_________________

For more:

Category:

Activism, vaccines, Viruses

Comments Off on Measles Eradication Via Vaccination: The Ultimate Nirvana Fallacy